Author:

Keywords:

Science & Technology, Life Sciences & Biomedicine, Dentistry, Oral Surgery & Medicine, Microbiology, ATCC PTA 5289, glycerol, Limosilactobacillus reuteri, periodontitis, probiotic, synbiotics, FULL-MOUTH DISINFECTION, TUMOR-NECROSIS-FACTOR, LACTOBACILLUS-REUTERI, MUTANS STREPTOCOCCI, CHRONIC PERIODONTITIS, OXIDATIVE STRESS, DOUBLE-BLIND, ASSOCIATION, SUPPLEMENTS, MICROBIOTA, Humans, Glycerol, Synbiotics, Probiotics, Biofilms, Anti-Bacterial Agents, Anti-Infective Agents, Periodontitis, G091218N#54518653, C24/17/086#54270821, 1105 Dentistry, 1107 Immunology, 1108 Medical Microbiology, Dentistry, 3203 Dentistry

Abstract:

Both in vitro and in vivo studies have shown that the probiotic Limosilactobacillus reuteri can improve oral health. Limosilactobacillus reuteri species are known to produce the antimicrobial "reuterin" from glycerol. In order to further increase its antimicrobial activity, this study evaluated the effect of the combined use of glycerol and Limosilactobacillus reuteri (ATCC PTA 5289) in view of using a synergistic synbiotic over a probiotic. An antagonistic agar growth and a multispecies biofilm model showed that the antimicrobial potential of the probiotic was significantly enhanced against periodontal pathobionts and anaerobic commensals when supplemented with glycerol. Synbiotic biofilms also showed a significant reduction in inflammatory expression of human oral keratinocytes (HOK-18A), but only when the keratinocytes were preincubated with the probiotic. Probiotic preincubation of keratinocytes or probiotic and synbiotic treatment of biofilms alone was insufficient to significantly reduce inflammatory expression. Overall, this study shows that combining glycerol with the probiotic L. reuteri into a synergistic synbiotic can greatly improve the effectiveness of the latter.